This year The Lancet Magazine published a 20-year follow-up showing long-term antipsychotics shrink brain volume by 8% and cut life expectancy by 15–20 years. Most users are on them for life after one psychotic episode. In a shocking October 2025 New York Times investigation, whistleblowers revealed pharma companies hid 2024 trial data linking drugs like Risperdal to 25% higher sudden cardiac deaths in youth, prompting FDA hearings that exposed over-prescription—up 40% since 2020. A September 2025 JAMA study confirms that digestive syndromes affect 60% of users taking antipsychotic meds, fueling a class-action lawsuit by 5,000 families.
“Antipsychotic Meds Causing Brain Shrinkage & Early Death”
These statement have not been evaluated by the Food and Drug Administration. Products or services at Gilead Balm are not intended to diagnose, treat, cure, or prevent any disease.